AC Immune exclusive option and license agreement with Takeda Pharmaceuticals
We advised AC Immune on the transaction
Experience
To find Davis Polk deals and cases of particular interest, select filters based on practice, industry, region, lawyer and keyword.
Filters
Fiserv $2 billion notes offering
The investment-grade debt consists of three tranches of notes
Novo Nordisk acquisition of certain Catalent sites from Novo Holdings
We are advising Novo Nordisk on the acquisition
GSK exclusive license agreement for HS-20093 with Hansoh Pharma
We advised GSK on the transaction
GSK exclusive license agreement for HS-20089 with Hansoh Pharma
We advised GSK on the transaction
GSK collaboration extension and new data licensing agreement with 23andMe
We advised GSK on the transaction
Fiserv $2 billion notes offering
The investment-grade debt consists of two tranches of notes
BMS $35 million investment in Immatics
We advised Immatics on the private placement of ordinary shares
Centogene strategic collaboration with Lifera
We are advising Centogene on its joint venture with and convertible debt investment by Lifera
Fiserv €800 million notes offering
The investment-grade notes are due 2031